/Bio-Techne%20Corp%20sign-by%20JHVEPhoto%20via%20Shutterstock.jpg)
Bio-Techne has underperformed the biotechnology industry over the past year, but analysts are highly optimistic about the stock’s prospects.
Bio-Techne has underperformed the broader market over the past year, yet analysts remain bullish on the stock’s prospects.
The S&P 500 Index ($SPX ) (SPY ) Wednesday closed down -0.33%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.22%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.79%. Stocks Wednesday...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.17%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.16%. Strength in tech stocks today...
The S&P 500 Index ($SPX ) (SPY ) today is down -0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.50%. Stocks today gave up overnight...
/Bio-Techne%20Corp%20logo%20and%20data-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Bio-Techne Corporation is expected to release its fiscal first-quarter earnings later this month, and analysts project a low single-digit profit decline.
Bio-Techne has underperformed the healthcare sector over the past year, yet analysts remain strongly bullish about the stock’s prospects.
Bio-Techne has underperformed the broader market this year, but Wall Street analysts are optimistic about the stock’s prospects.
The S&P 500 Index ($SPX ) (SPY ) Wednesday closed down -0.77%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.60%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.16%. US stock...